IP Library Granted Patent US 9,463,273
Granted Patent B2
US 9,463,273 · App. 14/278,194 · Granted Oct 11, 2016

Drug delivery apparatus and method for automatically reducing drug dosage

Inventor: Brian Michael Shelton (Pasadena, CA)
Assignee: Medallion Therapeutics, Inc.
A61M5/14276A61K9/0097A61M5/172A61K9/0019A61K9/0024A61M5/16827A61M2005/14208A61M2205/3523A61M2205/3561A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,463,273
App. No.
14/278,194
Granted
Oct 11, 2016
Kind
B2
Abstract

A drug delivery device which includes a fluid drug reservoir, a catheter, a controllable fluid transfer device, e.g., a pump mechanism or valve, and a drug delivery control means: The drug delivery control means comprises a controller, e.g., a microprocessor or microcontroller which is operable to automatically reduce the rate of drug delivery over a certain reduction interval (e.g., multiple days) from an initial dosage value to a final dosage value.

Claims (27)

1. A method delivering drug with a drug delivery device located entirely within a patient, the method comprising the steps of:

wirelessly receiving delivery data with the drug delivery device located entirely within the patient; and

without receiving additional delivery data

(1) supplying drug to the patient for a period of at least 2 hours in accordance with a first stored delivery profile that includes a plurality of delivery times and a plurality of first delivery rates that correspond to the delivery times;

(2) after step (1), supplying drug to the patient for a period of at least 2 hours in accordance with a second stored delivery profile that includes a plurality of delivery times and a plurality of second delivery rates that correspond to the delivery times and are respectively lower than the first delivery rates, and

(3) after step (2), supplying drug to the patient for a period of at least 2 hours in accordance with a third stored delivery profile that includes a plurality of delivery times and a plurality of third delivery rates that correspond to the delivery times and are respectively lower than the second delivery rates.

2. A method as claimed in claim 1 , wherein wirelessly receiving delivery data comprises wirelessly receiving a periodic reduction ratio with the drug delivery device located entirely within the patient.

3. A method as claimed in claim 1 , wherein wirelessly receiving delivery data comprises wirelessly receiving a periodic reduction ratio, a reduction period, and a reduction interval with the drug delivery device located entirely within the patient.

4. A method as claimed in claim 1 , wherein wirelessly receiving delivery data comprises wirelessly receiving data based on a current dosage, a final dosage, and a reduction rate with the drug delivery device located entirely within the patient.

5. A method as claimed in claim 1 , wherein wirelessly receiving delivery data comprises wirelessly receiving data based on a current dosage value, a final dosage value, and a detoxification duration with the drug delivery device located entirely within the patient.

6. A method as claimed in claim 1 , wherein the period during which drug is supplied to the patent in accordance with the first delivery profile is at least about 24 hours.

7. A method as claimed in claim 6 , wherein the period during which drug is supplied to the patent in accordance with the second delivery profile is at least about 24 hours.

8. A method as claimed in claim 7 , wherein the period during which drug is supplied to the patent in accordance with the third delivery profile is at least about 24 hours.

9. A method as claimed in claim 1 , wherein at least two of the first delivery rates are different non-zero delivery rates.

10. A method as claimed in claim 1 , wherein supplying drug to the patient comprises supplying drug to the patient with a pump mechanism.

11. A method delivering drug with a drug delivery device located entirely within a patient, the method comprising the steps of:

storing a 24-hour delivery profile that includes one or more delivery rates in the drug delivery device located entirely within the patient;

wirelessly receiving a final daily dosage value with the drug delivery device located entirely within the patient;

wirelessly receiving a reduction rate or a reduction interval with the drug delivery device located entirely within the patient; and

without receiving additional delivery profile information with the drug delivery device located entirely within the patient

delivering drug to the patient in accordance with the 24-hour delivery profile that include one or more delivery rates, and then

delivering drug to the patient in accordance with a reduced 24-hour delivery profile that includes one or more reduced delivery rates that are functions of the one or more delivery rates and either the transmitted final daily dosage value and the transmitted reduction rate or the transmitted final daily dosage value and the transmitted reduction interval, and then

delivering drug to the patient in accordance with a further reduced 24-hour delivery profile that includes one or more reduced delivery rates that are functions of the one or more reduced delivery rates and either the transmitted final daily dosage value and the transmitted reduction rate or the transmitted final daily dosage value and the transmitted reduction interval.

12. A method as claimed in claim 11 , wherein the 24-hour delivery profile includes at least two non-zero delivery rates that are different than one another.

13. A method as claimed in claim 11 , wherein wirelessly receiving a reduction rate or a reduction interval comprises wirelessly receiving a reduction rate with the drug delivery device located entirely within the patient.

14. A method as claimed in claim 11 , wherein wirelessly receiving a reduction rate or a reduction interval comprises wirelessly receiving a reduction interval with the drug delivery device located entirely within the patient.

15. A method as claimed in claim 11 , wherein delivering drug to the patient comprises delivering drug to the patient with a pump mechanism.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2021
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 057962/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2019
From: MEDALLION THERAPEUTICS, INC.
To: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 051287/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2015
From: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDALLION THERAPEUTICS, INC.
Reel/Frame 034815/0547 →
Continuity (4)
Continuation 13281432 · Oct 26, 2011
Continuation 11182307 · Jul 14, 2005
Provisional Application 60604999 · Aug 27, 2004
Related Publication 20140364839A1 · Dec 11, 2014